SCHEMBL17280115

SCHEMBL17280115

CCCC(=O)Oc1ccc(-c2nc(-c3cccc(-c4n[nH]c(-c5ccc(OC(=O)CCC)cc5)n4)c3)n[nH]2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 5/20 0.50
▸ NR1H3 Q13133 5/20 0.50
▸ RAB9A P51151 3/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ ADORA2A P29274 3/20 0.45
▸ ADORA1 P30542 3/20 0.45
▸ ADORA3 P0DMS8 2/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ ATAD2 Q6PL18 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ S1PR1 P21453 1/20 0.43
▸ GRK6 P43250 1/20 0.41
▸ BCL9 O00512 1/20 0.41
▸ CTNNB1 P35222 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17280112 0.90 NR1H2 (0.52) NR1H2NR1H3RAB9AKMT2AADORA2A
SCHEMBL17280113 0.83 NR1H2 (0.50) NR1H2NR1H3RAB9AKMT2AADORA2A
SCHEMBL17280111 0.79 GAA (0.47) NR1H2NR1H3RAB9AKMT2AADORA2A
SCHEMBL17280052 0.79 NPC1 (0.56) NR1H2NR1H3RAB9AKMT2AADORA2A
SCHEMBL17279736 0.79 LMNA (0.51) NR1H2NR1H3RAB9AKMT2AADORA2A
SCHEMBL17279973 0.77 RAB9A (0.48) RAB9AKMT2ANPC1MEN1MAPT
SCHEMBL17280100 0.76 NPC1 (0.52) NR1H2NR1H3RAB9AKMT2AADORA2A
SCHEMBL17280098 0.75 MAPT (0.54) NR1H2NR1H3RAB9AKMT2AADORA2A
SCHEMBL17280065 0.75 NR1H2 (0.57) NR1H2NR1H3RAB9AKMT2AADORA2A
SCHEMBL27959667 0.75 ADORA3 (0.56) NR1H2NR1H3KMT2AADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020149206-A1 METHOD FOR PRODUCING ACRYLIC RESIN FILM コニカミノルタ株式会社 2020-07-23 — — WO disclosed
US-20180203175-A1 TRIAZOLE COMPOUND Konica Minolta, Inc. (JP) 2018-07-19 — — US disclosed
US-20180203175-A1 TRIAZOLE COMPOUND Konica Minolta, Inc. (JP) 2018-07-19 — — US disclosed
US-10012777-B2 Resin composition Konica Minolta, Inc. (JP) 2018-07-03 — — US disclosed
US-10012777-B2 Resin composition Konica Minolta, Inc. (JP) 2018-07-03 — — US disclosed
WO-2017099041-A1 POLYIMIDE FILM, FLEXIBLE PRINTED BOARD, LED LIGHTING DEVICE ETC. コニカミノルタ株式会社 2017-06-15 — — WO disclosed
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE KONICA MINOLTA, INC (JP) 2015-11-26 — — US disclosed
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE KONICA MINOLTA, INC (JP) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE HRH3, HELZ, NBAS NR1H2 1059/4885NR1H3 766/4885RAB9A 1803/4885
US-10012777-B2 Resin composition NBAS, WDR5, HRH3 NR1H2 1877/4885NR1H3 1458/4885RAB9A 2127/4885
US-20180203175-A1 TRIAZOLE COMPOUND H1-10, TTI2, H1-2 NR1H2 534/4885NR1H3 787/4885RAB9A 1962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback